DRUG
Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc. (DRUG) is currently in a range/mixed trend, trading above both the 50-day and 200-day moving averages. RSI is at 57.7, with 2/3 trend checks passing.
DRUG with MA50 and MA200
Key levels & signals
Bright Minds Biosciences Inc. (DRUG) looks more range-bound than strongly trending, but there are still a few supportive signs on the chart. The latest available price is $75.92, and 2 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 2.4% and above the 200-day moving average by 1.6%.
DRUG currently has an RSI reading of 57.7, which leans mildly positive without looking too stretched. In other words, momentum is supportive, but not yet extreme enough to dominate the entire chart read.
This page is designed to help you quickly understand what the DRUG chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.
About Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company’s BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
Learn the indicators behind this page
More stock opportunities
Common questions about DRUG
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.